0000899243-22-012148.txt : 20220324 0000899243-22-012148.hdr.sgml : 20220324 20220324194450 ACCESSION NUMBER: 0000899243-22-012148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220322 FILED AS OF DATE: 20220324 DATE AS OF CHANGE: 20220324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aivado Manuel CENTRAL INDEX KEY: 0001709603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 22767913 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-22 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001709603 Aivado Manuel C/O AILERON THERAPEUTICS, INC. 285 SUMMER STREET, SUITE 101 BOSTON MA 02210 1 1 0 0 See Remarks Stock Option (right to buy) 0.44 2022-03-22 4 A 0 1133000 0.00 A 2032-03-21 Common Stock 1133000 1133000 D This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026. President and Chief Executive Officer /s/ Richard Wanstall, attorney in fact for Manuel Aivado 2022-03-24